Exelixis
EXEL
#1557
Rank
S$18.09 B
Marketcap
S$73.01
Share price
-1.95%
Change (1 day)
43.91%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company